Investing.com - Teva ADR reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Teva ADR announced earnings per share of $0.59 on revenue of $3.89B. Analysts polled by Investing.com anticipated EPS of $0.6463 on revenue of $4.03B.
Teva ADR shares are up 5% from the beginning of the year and are trading at $9.39 , down-from-52-week-high.They are under-performing the Nasdaq 100 which is up 20.73% from the start of the year.
Teva ADR follows other major Healthcare sector earnings this month
Teva ADR's report follows an earnings beat by J&J on Tuesday, October 19, 2021, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.35 on revenue of $23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of $5.76 on revenue of $9.33B, compared to forecast for EPS of $4.68 on revenue of $8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar